Abstract:Abstract Biomarker tests of Alzheimer’s disease (AD) are invasive and expensive. Recent developments in optical coherence tomography (OCT) and OCT angiography (OCTA) have enabled noninvasive, cost-effective characterization of retinal layer vasculature and thickness. Using OCTA and OCT, we characterized retinal microvascular changes in the mild cognitive impairment (MCI) stage of AD and assessed their correlation with structural changes in each retinal neuronal layer. We also evaluated the effect of the APOE-ε4 genotype on retinal microvasculature and layer thickness. Retinal layer thickness did not differ between MCI patients (40 eyes) and controls (37 eyes, all p > 0.05). MCI patients had lower vessel density (VD) (p = 0.003) of the superficial capillary plexus (SCP) and larger foveal avascular zone area (p = 0.01) of the deep capillary plexus (DCP) than those of controls. VD of the SCP correlated with the ganglion cell layer (r = 0.358, p = 0.03) and inner plexiform layer thickness (r = 0.437, p = 0.007) in MCI patients. APOE-ε4 -carrying MCI patients had a lower VD of the DCP than non-carriers (p = 0.03). In conclusion, retinal microvasculature was reduced in patients with AD-associated MCI, but retinal thickness was not changed; these changes might be affected by the APOE genotype. OCTA of the retinal microvasculature may be useful to detect vascular changes in AD.

What problem does this paper attempt to address?

This paper aims to explore the retinal microvascular changes in patients with mild cognitive impairment (MCI) related to Alzheimer's disease (AD) and their relationship with the structural changes of the retinal nerve layer, and to evaluate the impact of apolipoprotein E (APOE - ε4) genotype on these changes. Specifically, the researchers used optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) techniques to analyze the differences in the thickness of each retinal layer and retinal microvascular density (VD) between MCI patients and the control group, and further explored the relationship between these changes and the APOE - ε4 genotype. The research background points out that current biomarker detection methods for Alzheimer's disease, such as positron emission tomography (PET) or cerebrospinal fluid tests, are effective but invasive and costly. Therefore, finding non - invasive, technically simple and economical biomarkers is crucial for the early diagnosis and treatment monitoring of AD. The retina is considered a potential AD biomarker because of its anatomical and physiological characteristics similar to those of the brain and the fact that it can be non - invasively evaluated using high - resolution imaging techniques such as OCT. Through this study, the authors hope to verify whether the changes in retinal microvasculature can be used as a biomarker in the early stage of AD, especially for patients in the MCI stage, and whether these changes are affected by the APOE - ε4 genotype. This finding will not only help to understand the pathological mechanism of AD, but may also provide new imaging targets for the early diagnosis of AD.

Changes in retinal microvasculature and retinal layer thickness in association with apolipoprotein E genotype in Alzheimer’s disease